{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:17:40Z","timestamp":1783408660022,"version":"3.54.6"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ajem.2021.06.065","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T11:55:55Z","timestamp":1625486155000},"page":"316-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions"],"prefix":"10.1016","volume":"48","author":[{"given":"Ali","family":"Pourmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamilla","family":"Beisenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nebiyu","family":"Shukur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Tebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakita","family":"Mortimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Mazer-Amirshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2021.06.065_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bja.2017.11.086","article-title":"Efficacy and adverse effects of buprenorphine in acute pain management: systematic review and meta-analysis of randomised controlled trials","author":"White","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ajem.2021.06.065_bb0010","series-title":"Drug overdose","author":"Data Overview","year":"2020"},{"issue":"2","key":"10.1016\/j.ajem.2021.06.065_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ajem.2021.06.065_bb0020","author":"Scholl"},{"key":"10.1016\/j.ajem.2021.06.065_bb0025","doi-asserted-by":"crossref","unstructured":"Morbidity and Mortality Weekly Report. doi:https:\/\/doi.org\/10.2105\/AJPH.2014.302367?journalCode=ajph","DOI":"10.2105\/AJPH.2014.302367"},{"issue":"1","key":"10.1016\/j.ajem.2021.06.065_bb0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: a review of evidence in both developed and developing worlds","volume":"3","author":"Whelan","year":"2012","journal-title":"J Neurosci Rural Pract"},{"issue":"6","key":"10.1016\/j.ajem.2021.06.065_bb0035","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.annemergmed.2018.01.052","article-title":"Opportunities for prevention and intervention of opioid overdose in the emergency department hhs public access","volume":"71","author":"Houry","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2021.06.065_bb0045","series-title":"Buprenorphine pharmacology review: update on transmucosal and long-acting formulations","author":"Coe","year":"2019"},{"issue":"1","key":"10.1016\/j.ajem.2021.06.065_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0376-8716(99)00012-5","article-title":"Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet","volume":"56","author":"Schuh","year":"1999","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.ajem.2021.06.065_bb0055","first-page":"178","article-title":"Buprenorphine is an antagonist at the \u03f0 opioid receptor","volume":"2","author":"Richards","year":"1985","journal-title":"Pharm Res An Off J Am Assoc Pharm Sci"},{"issue":"4","key":"10.1016\/j.ajem.2021.06.065_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jsat.2010.01.006","article-title":"Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment","volume":"38","author":"M\u00e9garbane","year":"2010","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.ajem.2021.06.065_bb0065","series-title":"Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs","author":"Volpe","year":"2011"},{"issue":"6","key":"10.1016\/j.ajem.2021.06.065_bb0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/jcpt.12196","article-title":"The clinical analgesic efficacy of buprenorphine","volume":"39","author":"Raffa","year":"2014","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"10.1016\/j.ajem.2021.06.065_bb0075","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2337\/dc16-0123","article-title":"Transdermal buprenorphine relieves neuropathic pain: a randomized, double-blind, parallel-group, placebo-controlled trial in diabetic peripheral neuropathic pain","volume":"39","author":"Simpson","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajem.2021.06.065_bb0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2147\/JPR.S85951","article-title":"Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain","volume":"8","author":"Pillarisetti","year":"2015","journal-title":"J Pain Res"},{"key":"10.1016\/j.ajem.2021.06.065_bb0085","series-title":"Buprenorphine-related deaths among drug addicts in france: a report on 20 fatalities","volume":"22","author":"Tracqui","year":"1998"},{"issue":"3","key":"10.1016\/j.ajem.2021.06.065_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/10550490050148099","article-title":"Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine","volume":"9","author":"Petry","year":"2000","journal-title":"Am J Addict"},{"issue":"6","key":"10.1016\/j.ajem.2021.06.065_bb0095","first-page":"715","article-title":"Equipotent doses to switch from high doses of opioids to transdermal buprenorphine","volume":"17","author":"Mercadante","year":"2009","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.ajem.2021.06.065_bb0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajem.2021.06.065_bb0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0009922819829038","article-title":"Buprenorphine overdose in young children: an underappreciated risk","volume":"58","author":"Lo Re","year":"2019","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"10.1016\/j.ajem.2021.06.065_bb0110","doi-asserted-by":"crossref","first-page":"e782","DOI":"10.1542\/peds.2007-1774","article-title":"Toxicity of buprenorphine overdoses in children","volume":"121","author":"Hayes","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajem.2021.06.065_bb0115","series-title":"Lack of effect of single high doses of buprenorphine on arterial blood gases in the rat","author":"Borron","year":"2001"},{"issue":"12","key":"10.1016\/j.ajem.2021.06.065_bb0120","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/pme.12520","article-title":"Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients","volume":"15","author":"Daitch","year":"2014","journal-title":"Pain Med (United States)"},{"issue":"5","key":"10.1016\/j.ajem.2021.06.065_bb0125","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/bja\/ael051","article-title":"Buprenorphine induces ceiling in respiratory depression but not in analgesia","volume":"96","author":"Dahan","year":"2006","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.ajem.2021.06.065_bb0130","doi-asserted-by":"crossref","first-page":"e1700","DOI":"10.1542\/peds.2012-1342","article-title":"Buprenorphine may not be as safe as you think: a pediatric fatality from unintentional exposure","volume":"130","author":"Kim","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ajem.2021.06.065_bb0135","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3652","article-title":"Buprenorphine exposures among children and adolescents reported to us poison control centers","volume":"142","author":"Post","year":"2018","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ajem.2021.06.065_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajem.2021.06.065_bb0145","series-title":"Buprenorphine quick start guide","author":"Substance Abuse and Mental health Services Administration (SAMHSA)","year":"2021"},{"key":"10.1016\/j.ajem.2021.06.065_bb0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.annemergmed.2018.11.032","article-title":"Managing opioid withdrawal in the emergency department with buprenorphine","volume":"73","author":"Herring","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2021.06.065_bb0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jsat.2010.12.002","article-title":"A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions","volume":"40","author":"Cunningham","year":"2011","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.ajem.2021.06.065_bb0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2004.07.008","article-title":"A double-blind, double-dummy, randomized, prospective pilot study of the partial Mu opiate agonist, buprenorphine, for acute detoxification from heroin","volume":"77","author":"Oreskovich","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"10229","key":"10.1016\/j.ajem.2021.06.065_bb0165","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ajem.2021.06.065_bb0170","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/add.13900","article-title":"Cost-effectiveness of emergency department-initiated treatment for opioid dependence","volume":"112","author":"Busch","year":"2017","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.ajem.2021.06.065_bb0175","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1097\/ADM.0000000000000682","article-title":"Low barrier tele-buprenorphine in the time of COVID-19: a case report","volume":"14","author":"Harris","year":"2020","journal-title":"J Addict Med"},{"key":"10.1016\/j.ajem.2021.06.065_bb0180","series-title":"Medicaid coverage of medication-assisted treatment for alcohol and opioid use disorders and of medication for the reversal of opioid overdose. HHS publication no. SMA-18-5093","author":"Abuse","year":"2018"},{"issue":"4","key":"10.1016\/j.ajem.2021.06.065_bb0185","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3132","article-title":"Association of formulary prior authorization policies with buprenorphine-naloxone prescriptions and hospital and emergency department use among medicare beneficiaries","volume":"3","author":"Mark","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ajem.2021.06.065_bb0190","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department\u2013initiated buprenorphine","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ajem.2021.06.065_bb0195","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/emp2.12289","article-title":"Microdosing and standard-dosing take-home buprenorphine from the emergency department: a feasibility study","volume":"1","author":"Moe","year":"2020","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"10.1016\/j.ajem.2021.06.065_bb0200","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.ajem.2021.06.065_bb0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/OAEM.S267416","article-title":"Prescribing buprenorphine for opioid use disorders in the ED: a review of best practices, barriers, and future directions","volume":"12","author":"Cao","year":"2020","journal-title":"Open Access Emerg Med"},{"issue":"16","key":"10.1016\/j.ajem.2021.06.065_bb0210","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D'Onofrio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2021.06.065_bb0215","article-title":"Consult","author":"ARUP","year":"2021","journal-title":"Drug Test"},{"key":"10.1016\/j.ajem.2021.06.065_bb0220","first-page":"1","article-title":"Buprenorphine Field Initiation of ReScue Treatment by Emergency Medical Services (Bupe FIRST EMS): a case series [published online ahead of print, 2020 May 4]","author":"Carroll","year":"2020","journal-title":"Prehosp Emerg Care"},{"issue":"3","key":"10.1016\/j.ajem.2021.06.065_bb0225","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11524-008-9270-2","article-title":"Homelessness and the response to emerging infectious disease outbreaks: lessons from SARS","volume":"85","author":"Leung","year":"2008","journal-title":"J Urban Health"},{"issue":"2","key":"10.1016\/j.ajem.2021.06.065_bb0230","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11524-014-9866-7","article-title":"Psychiatric comorbidity, red flag behaviors, and associated outcomes among office-based buprenorphine patients following Hurricane Sandy","volume":"91","author":"Williams","year":"2014","journal-title":"J Urban Health"},{"key":"10.1016\/j.ajem.2021.06.065_bb0235","first-page":"1","article-title":"Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine [published online ahead of print, 2020 Feb 20]","author":"Brunet","year":"2020","journal-title":"Subst Abus"},{"issue":"2","key":"10.1016\/j.ajem.2021.06.065_bb0250","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.annemergmed.2020.02.020","article-title":"Providing incentive for emergency physician X-waiver training: an evaluation of program success and postintervention buprenorphine prescribing","volume":"76","author":"Foster","year":"2020","journal-title":"Ann Emerg Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721005519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721005519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:56:07Z","timestamp":1760025367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721005519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":47,"alternative-id":["S0735675721005519"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.06.065","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.06.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}